A 3D Platform to Investigate Dynamic Cell-to-Cell Interactions Between Tumor Cells and Mesenchymal Progenitors

被引:4
作者
Golinelli, Giulia [1 ]
Talami, Rebecca [1 ]
Frabetti, Stella [2 ]
Candini, Olivia [2 ]
Grisendi, Giulia [1 ]
Spano, Carlotta [2 ]
Chiavelli, Chiara [1 ]
Arnaud, Gaelle F. [3 ]
Mari, Giorgio [2 ,3 ]
Dominici, Massimo [1 ,2 ]
机构
[1] Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Div Oncol, Modena, Italy
[2] Rigenerand Srl, Medolla, Italy
[3] Sci & Technol Pk Med, Tecnopolo Mirandola Mario Veronesi, Mirandola, Italy
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2022年 / 9卷
关键词
ewing's sarcoma; 3D cell cultures; bioreactor; tumor-stroma interaction; mesenchymal stromal; stem cells; ddPCR; fluidic circuit; cancer therapy; STEM-CELLS; EWING SARCOMA; IN-VITRO; CANCER; EXPRESSION; MICROENVIRONMENT; SIMILARITIES; FIBROBLASTS; CROSSTALK; APOPTOSIS;
D O I
10.3389/fcell.2021.767253
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We here investigated the dynamic cell-to-cell interactions between tumor and mesenchymal stromal/stem cells (MSCs) by the novel VITVOCIRCLED LATIN CAPITAL LETTER R 3D bioreactor that was customized to develop in vivo-like metastatic nodules of Ewing's sarcoma (ES). MSCs are known to contribute to tumor microenvironment as cancer associated fibroblast (CAF) precursors and, for this reason, they have also been used as anti-cancer tools. Using dynamic conditions, the process of tissue colonization and formation of metastatic niches was recreated through tumor cell migration aiming to mimic ES development in patients. ES is an aggressive tumor representing the second most common malignant bone cancer in children and young adults. An urgent and unmet need exists for the development of novel treatment strategies to improve the outcomes of metastatic ES. The tumor-tropic ability of MSCs offers an alternative approach, in which these cells can be used as vehicles for the delivery of antitumor molecules, such as the proapoptotic TNF-related apoptosis inducing ligand (TRAIL). However, the therapeutic targeting of metastases remains challenging and the interaction occurring between tumor cells and MSCs has not yet been deeply investigated. Setting up in vitro and in vivo models to study this interaction is a prerequisite for novel approaches where MSCs affinity for tumor is optimized to ultimately increase their therapeutic efficacy. Here, VITVOCIRCLED LATIN CAPITAL LETTER R integrating a customized scaffold with an increased inter-fiber distance (VITVO50) was used to develop a dynamic model where MSCs and tumor nodules were evaluated under flow conditions. Colonization and interaction between cell populations were explored by droplet digital PCR (ddPCR). VITVO50 findings were then applied in vivo. An ES metastatic model was established in NSG mice and biodistribution of TRAIL-expressing MSCs in mice organs affected by metastases was investigated using a 4-plex ddPCR assay. VITVOCIRCLED LATIN CAPITAL LETTER R proved to be an easy handling and versatile bioreactor to develop in vivo-like tumor nodules and investigate dynamic cell-to-cell interactions with MSCs. The proposed fluidic system promises to facilitate the understanding of tumor-stroma interaction for the development of novel tumor targeting strategies, simplifying the analysis of in vivo data, and ultimately accelerating the progress towards the early clinical phase.
引用
收藏
页数:14
相关论文
共 53 条
  • [1] Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-1
    Barcellos-de-Souza, Pedro
    Comito, Giuseppina
    Pons-Segura, Coral
    Taddei, Maria Letizia
    Gori, Valentina
    Becherucci, Valentina
    Bambi, Franco
    Margheri, Francesca
    Laurenzana, Anna
    Del Rosso, Mario
    Chiarugi, Paola
    [J]. STEM CELLS, 2016, 34 (10) : 2536 - 2547
  • [2] Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2
    Belema-Bedada, Fikru
    Uchida, Shizuka
    Martire, Alessandra
    Kostin, Sawa
    Braun, Thomas
    [J]. CELL STEM CELL, 2008, 2 (06) : 566 - 575
  • [3] A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology
    Candini, Olivia
    Grisendi, Giulia
    Foppiani, Elisabetta Manuela
    Brogli, Matteo
    Aramini, Beatrice
    Masciale, Valentina
    Spano, Carlotta
    Petrachi, Tiziana
    Veronesi, Elena
    Conte, Pierfranco
    Mari, Giorgio
    Dominici, Massimo
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
    Casey, Dana L.
    Lin, Tsung-Yi
    Cheung, Nai-Kong, V
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [5] CHANG HR, 1992, CANCER, V70, P633, DOI 10.1002/1097-0142(19920801)70:3<633::AID-CNCR2820700315>3.0.CO
  • [6] 2-F
  • [7] Ewing sarcoma
    Choi, Eun-Young K.
    Gardner, Jerad M.
    Lucas, David R.
    McHugh, Jonathan B.
    Patel, Rajiv M.
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2014, 31 (01) : 39 - 47
  • [8] The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells
    Coffelt, Seth B.
    Marini, Frank C.
    Watson, Keri
    Zwezdaryk, Kevin J.
    Dembinski, Jennifer L.
    LaMarca, Heather L.
    Tomchuck, Suzanne L.
    Bentrup, Kerstin Honer zu
    Danka, Elizabeth S.
    Henkle, Sarah L.
    Scandurro, Aline B.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) : 3806 - 3811
  • [9] Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
    Dobrenkov, Konstantin
    Ostrovnaya, Irina
    Gu, Jessie
    Cheung, Irene Y.
    Cheung, Nai-Kong V.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 (10) : 1780 - 1785
  • [10] DVORAK HF, 1986, NEW ENGL J MED, V315, P1650